carvedilol has been researched along with Chronic Kidney Diseases in 8 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Clinical guidelines suggest that for patients with heart failure and concurrent chronic obstructive pulmonary disease (COPD), metoprolol/bisoprolol/nebivolol should be preferred over carvedilol." | 3.91 | Beta-blocker choice and exchangeability in patients with heart failure and chronic obstructive pulmonary disease: an Italian register-based cohort study. ( Andersen, M; Capuano, A; Jensen, MT; Kragholm, K; Mascolo, A; Pagliaro, C; Rafaniello, C; Rasmussen, DB; Rossi, F; Sessa, M; Sportiello, L; Tari, GM, 2019) |
| "The utility of β-blockers in the treatment of hypertension has created much speculation as to their efficacy in patients with comorbid conditions, and there are concerns regarding their adverse metabolic effects." | 2.48 | Vasodilating versus first-generation β-blockers for cardiovascular protection. ( Fares, H; Lavie, CJ; Ventura, HO, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (87.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Sessa, M | 1 |
| Mascolo, A | 1 |
| Rasmussen, DB | 1 |
| Kragholm, K | 1 |
| Jensen, MT | 1 |
| Sportiello, L | 1 |
| Rafaniello, C | 1 |
| Tari, GM | 1 |
| Pagliaro, C | 1 |
| Andersen, M | 1 |
| Rossi, F | 1 |
| Capuano, A | 1 |
| Maekawa, M | 1 |
| Takahashi, A | 1 |
| Miki, Y | 1 |
| Roberts, MA | 1 |
| Darssan, D | 1 |
| Badve, SV | 1 |
| Carroll, RP | 1 |
| Fahim, MA | 1 |
| Haluska, BA | 1 |
| Hawley, CM | 1 |
| Isbel, NM | 1 |
| Marshall, MR | 1 |
| Pascoe, EM | 1 |
| Pedagogos, E | 1 |
| Pilmore, HL | 1 |
| Snelling, P | 1 |
| Stanton, T | 1 |
| Tan, KS | 1 |
| Tonkin, AM | 1 |
| Vergara, LA | 1 |
| Ierino, FL | 1 |
| Assimon, MM | 1 |
| Brookhart, MA | 1 |
| Fine, JP | 1 |
| Heiss, G | 1 |
| Layton, JB | 1 |
| Flythe, JE | 1 |
| Hanauer Schaab, E | 1 |
| Lanchote, VL | 1 |
| Balthazar Nardotto, GH | 1 |
| Marques Pereira, MP | 1 |
| Dantas, M | 1 |
| Paiva, CE | 1 |
| Barbosa Coelho, E | 1 |
| Hahn, L | 1 |
| Hahn, M | 1 |
| Fares, H | 1 |
| Lavie, CJ | 1 |
| Ventura, HO | 1 |
| Yasuda, G | 1 |
| Yatsu, K | 1 |
| Yamamoto, Y | 1 |
| Hirawa, N | 1 |
1 review available for carvedilol and Chronic Kidney Diseases
| Article | Year |
|---|---|
Vasodilating versus first-generation β-blockers for cardiovascular protection.
Topics: Adrenergic beta-Antagonists; Age Factors; Antihypertensive Agents; Benzopyrans; Blood Glucose; Blood | 2012 |
3 trials available for carvedilol and Chronic Kidney Diseases
| Article | Year |
|---|---|
Carvedilol and Cardiac Biomarkers in Dialysis Patients: Secondary Analysis of a Randomized Controlled Trial.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Biomarkers; Carbazoles; Carvedilol; Female; Heart Diseases | 2017 |
Effect of Lercanidipine on the Pharmacokinetics-Pharmacodynamics of Carvedilol Enantiomers in Patients With Chronic Kidney Disease.
Topics: Administration, Oral; Adult; Antihypertensive Agents; Carvedilol; Case-Control Studies; Cross-Over S | 2020 |
Effects of carvedilol as third-line add-on therapy on blood pressure and glucose metabolism in type 2 diabetic patients with chronic renal disease stage 3 and above.
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin Receptor Antagonists; Antihypertensive Agents; Blood | 2012 |
4 other studies available for carvedilol and Chronic Kidney Diseases
| Article | Year |
|---|---|
Beta-blocker choice and exchangeability in patients with heart failure and chronic obstructive pulmonary disease: an Italian register-based cohort study.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Atrioventricular Block; Bisoprolol; Carvedilol | 2019 |
Carvedilol Associated Hypoglycemia in a Diabetic Patient on Maintenance Hemodialysis.
Topics: Adrenergic beta-Antagonists; Carbazoles; Carvedilol; Diabetic Nephropathies; Female; Humans; Hypogly | 2017 |
A Comparative Study of Carvedilol Versus Metoprolol Initiation and 1-Year Mortality Among Individuals Receiving Maintenance Hemodialysis.
Topics: Adrenergic beta-1 Receptor Antagonists; Aged; Carvedilol; Cohort Studies; Female; Humans; Male; Meto | 2018 |
Carvedilol-induced hyperkalemia in a patient with chronic kidney disease.
Topics: Adrenergic beta-Antagonists; Aged; Atrial Fibrillation; Carbazoles; Carvedilol; Dose-Response Relati | 2015 |